The warehouse retailer has announced that the prescriptions will be accessed via its new weight-loss program, operated by healthcare partner Sesame, according to a USA Today report
In December 2024, the TRIUMPH-4 Phase 3 trial results were announced, showing that participants taking retatrutide 12 mg achieved an average weight loss of 71.8 pounds or 28.7% of body weight over 68 weeks
Principales efectos adversos a vigilar (con evidencia cientfica) 1
Based on this information, personalized diet and exercise plans should be developed to ensure that the recommended interventions are tailored to the specific circumstances of atherosclerosis patients
Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE
Whether you're seeking to address health concerns, boost your confidence, or simply feel more comfortable in your own skin, our weight loss program is designed to help you achieve your aesthetic aspirations